Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson's disease.

Mediators of Inflammation
Sushruta KoppulaDong-Kug Choi

Abstract

Reactive oxygen species (ROSs) are emerging as important players in the etiology of neurodegenerative disorders including Parkinson's disease (PD). Out of several ROS-generating systems, the inflammatory enzymes nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and inducible nitric oxide synthase (iNOS) were believed to play major roles. Mounting evidence suggests that activation of NADPH oxidase and the expression of iNOS are directly linked to the generation of highly reactive ROS which affects various cellular components and preferentially damage midbrain dopaminergic neurons in PD. Therefore, appropriate management or inhibition of ROS generated by these enzymes may represent a therapeutic target to reduce neuronal degeneration seen in PD. Here, we have summarized recently developed agents and patents claimed as inhibitors of NADPH oxidase and iNOS enzymes in experimental models of PD.

References

Jan 1, 1990·Methods in Enzymology·B Halliwell, J M Gutteridge
Sep 13, 1986·Lancet·D G Altman, M J Gardner
Nov 1, 1993·British Journal of Pharmacology·M J GriffithsT W Evans
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·J L DinermanS H Snyder
Apr 15, 1994·European Journal of Pharmacology·R HattoriY Yui
Jan 10, 1995·Archives of Biochemistry and Biophysics·D J Wolff, A Lubeskie
Oct 31, 1994·Annals of the New York Academy of Sciences·A ArimuraD E Brenneman
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·J H PrehnR J Miller
Aug 1, 1994·Current Opinion in Neurology·J B Schulz, M F Beal
Jul 1, 1994·Journal of Neuropathology and Experimental Neurology·C S Raine
Aug 1, 1996·Stroke; a Journal of Cerebral Circulation·K M CockroftK J Tracey
Jan 1, 1996·Methods in Enzymology·Y Z YeJ S Beckman
Jun 12, 1997·Biochimica Et Biophysica Acta·J W VinceR A Reithmeier
Feb 5, 1998·Perceptual and Motor Skills·M S Chapell
Mar 17, 2000·Circulation Research·K K GriendlingM Ushio-Fukai
Dec 23, 2000·Molecular and Cellular Neurosciences·C KnottG P Wilkin
Mar 10, 2001·Journal of Neuroimmunology·M T Heneka, D L Feinstein
Apr 27, 2001·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·S P GreenJ T Curnutte
May 22, 2001·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·A CaggiatiP Pavone
Jan 17, 2002·Clinical Medicine : Journal of the Royal College of Physicians of London·H Connor
Mar 26, 2002·Brain : a Journal of Neurology·Tiina M TikkaJari Koistinaho
Oct 4, 2002·Muscle & Nerve·P L McGeer, E G McGeer
Oct 11, 2002·Journal of Neurology·E KoutsilieriP Riederer
Jan 18, 2003·The Journal of Clinical Investigation·Harry Ischiropoulos, Joseph S Beckman
Mar 22, 2003·The Journal of Pharmacology and Experimental Therapeutics·Yuxin LiuJau-Shyong Hong
Apr 1, 2003·Annals of Neurology·Peter Jenner
May 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Du-Chu WuSerge Przedborski

❮ Previous
Next ❯

Citations

Jul 9, 2013·Trends in Molecular Medicine·Ralf J LudwigEnno Schmidt
Dec 7, 2013·Molecular Medicine·Shingo MatsuoPing Wang
Aug 13, 2013·Mediators of Inflammation·Sandeep Vasant MoreDong-Kug Choi
Nov 13, 2013·Cellular and Molecular Life Sciences : CMLS·Hjalte Holm AndersenTorben Moos
Nov 21, 2012·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Jing BiLi-Jia An
Nov 9, 2016·Medical Gas Research·Qin HuJohn H Zhang
Oct 11, 2016·Mediators of Inflammation·Anna Niewiarowska-SendoIbeth Guevara-Lora
Jan 23, 2016·Scientific Reports·Jeremy S TorrisiBabak J Mehrara
Jun 18, 2015·Molecular Neurobiology·Matic PavlinJanez Mavri
Sep 2, 2017·Neurochemical Research·Francisco Arnaldo Viana LimaGlauce Socorro de Barros Viana
Jun 14, 2019·Medicinal Research Reviews·Maris A CinelliRichard B Silverman
Dec 3, 2013·Natural Product Reports·Hemant KumarDong-Kug Choi
Mar 14, 2020·Environmental Toxicology·Shih-Wei HsuDa-Tian Bau
Mar 14, 2020·Metabolomics : Official Journal of the Metabolomic Society·Poonam RanaNamas Chandra
Apr 25, 2019·Neurotoxicity Research·Sachchida Nand RaiSurya Pratap Singh
Jun 11, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Silvia GrottelliCristina Maccallini
Mar 23, 2019·Metabolic Brain Disease·Thelma Beatriz González-CastroJosé Jaime Martínez-Magaña
Nov 10, 2020·Environmental Science and Pollution Research International·Khalid Shaaban HashemMohamed M Abdel-Daim
Jan 25, 2020·Neurobiology of Disease·Aaron D SchwabR Lee Mosley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Related Papers

Antioxidants & Redox Signaling
Silvia Sorce, Karl-Heinz Krause
Expert Opinion on Therapeutic Patents
Jacques Joubert, Sarel F Malan
Nitric Oxide : Biology and Chemistry
Hisatoshi Sugiura, Masakazu Ichinose
Neurochemistry International
Ramendra N Saha, Kalipada Pahan
© 2021 Meta ULC. All rights reserved